اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 24, Issue 4 (مرداد و شهریور 2022) ::
Koomesh 2022, 24(4): 451-459 Back to browse issues page
Challenges of addiction treatment with opioid agonist drugs from the perspective of stakeholders: A qualitative study
Mohammad Bagher Saberi Zafarghandi , Neda Vahed , Hadi Ranjbar , Narges Saeidi , Mitra Shirazi
Abstract:   (1513 Views)
Introduction: Drug use disorder and dependency is one of the most challenging problems in the world. One of the most common therapy for opioid use disorder is agonist maintenance therapy especially methadone maintenance treatment and buprenorphine maintenance treatment. The study aimed to investigate the challenges of providing agonist therapy from the perspective of stakeholders. Materials and Methods: The present study is a qualitative study with a content analysis method that has used exploratory and semi-structured interviews and purposeful sampling. Interviews were conducted individually to collect data from the view of stakeholders including some of the physicians as service providers and a group of patients as service recipients. Sampling reached saturation with 21 people. The data were analyzed based on the Graneheim and Lundman model. Results: Data analysis revealed eight important challenges and barriers, including travel and time spent, availability of agonist drugs (used in maintenance therapy) illegally, take-home dose ( home dose of methadone), trust and confidentiality of authorities, the cost of treatment and income and expenditure, policy and cultural issues of the centers, file filing process, and family factors. Conclusion: The current pattern and the process of treatment with the agonist drugs reasonably have been well received. If the obstacles and problems of this treatment method are not considered, its useful results can face challenges.
Keywords: Agonist Drugs, Methadone, Buprenorphine, Treatment Challenges, Stakeholders, Qualitative Research
Full-Text [PDF 675 kb]   (687 Downloads)    
Type of Study: Research | Subject: General
Received: 2021/07/19 | Accepted: 2022/01/17 | Published: 2022/08/19
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.IUMS.REC.1398.037


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saberi Zafarghandi M B, Vahed N, Ranjbar H, Saeidi N, Shirazi M. Challenges of addiction treatment with opioid agonist drugs from the perspective of stakeholders: A qualitative study. Koomesh 2022; 24 (4) :451-459
URL: http://koomeshjournal.semums.ac.ir/article-1-7169-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 4 (مرداد و شهریور 2022) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645